| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |